Replimune Group Stock Price on December 26, 2024
| REPL Stock | USD 12.79 0.29 2.32% |
Below is the normalized historical share price chart for Replimune Group extending back to July 20, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Replimune stands at 12.79, as last reported on the 27th of December, with the highest price reaching 13.07 and the lowest price hitting 12.29 during the day.
If you're considering investing in Replimune Stock, it is important to understand the factors that can impact its price. Replimune appears to be somewhat reliable, given 3 months investment horizon. Replimune Group maintains Sharpe Ratio (i.e., Efficiency) of 0.0686, which implies the firm had a 0.0686% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Replimune Group, which you can use to evaluate the volatility of the company. Please evaluate Replimune's Semi Deviation of 3.2, risk adjusted performance of 0.0592, and Coefficient Of Variation of 1568.77 to confirm if our risk estimates are consistent with your expectations.
Stock Based Compensation is expected to rise to about 35.8 M this year, although the value of Total Stockholder Equity will most likely fall to about 291.7 M. . At this time, Replimune's Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 1.44 this year, although the value of Price Earnings To Growth Ratio will most likely fall to (0.30). Replimune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2018 | 200 Day MA 9.6282 | 50 Day MA 12.2532 | Beta 1.193 |
Replimune |
Sharpe Ratio = 0.0686
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | REPL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.76 actual daily | 51 51% of assets are less volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Replimune is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Replimune by adding it to a well-diversified portfolio.
Price Book 2.5218 | Book Value 5.577 | Enterprise Value 606 M | Enterprise Value Ebitda (0.24) | Shares Float 43.8 M |
Related Headline
Nuvectis Pharma Headline on 26th of December 2024
Ron Bentsur Increases Stake in Nuvectis Pharma Inc with Rece... by gurufocus.com
On December 24, 2024, Ron Bentsur, Chairman CEO, 10 percent Owner of Nuvectis Pharma Inc , acquired 4,500 shares of the company, according to a recent SEC Fili
Replimune Valuation on December 26, 2024
It is possible to determine the worth of Replimune on a given historical date. On December 26, 2024 Replimune was worth 12.36 at the beginning of the trading date compared to the closed value of 12.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Replimune stock. Still, in general, we apply an absolute valuation method to find Replimune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Replimune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Replimune's related companies.
| Open | High | Low | Close | Volume | |
| 12.21 | 12.59 | 12.12 | 12.50 | 329,481 | |
12/26/2024 | 12.36 | 13.07 | 12.29 | 12.79 | 400,443 |
| Backtest Replimune | | | Replimune History | | | Replimune Valuation | Previous |
Replimune Trading Date Momentum on December 26, 2024
| On December 26 2024 Replimune Group was traded for 12.79 at the closing time. The top price for the day was 13.07 and the lowest listed price was 12.29 . The trading volume for the day was 400.4 K. The trading history from December 26, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.36% . |
Replimune Group Fundamentals Correlations and Trends
By evaluating Replimune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Replimune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Replimune financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Replimune Stock history
Replimune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Replimune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Replimune Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Replimune stock prices may prove useful in developing a viable investing in Replimune
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 66.6 M | 47.1 M | |
| Net Loss | -106.2 M | -100.9 M |
Replimune Quarterly Net Working Capital |
|
Replimune Stock Technical Analysis
Replimune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Replimune Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Replimune Group cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Replimune December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Replimune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Replimune shares will generate the highest return on investment. By undertsting and applying Replimune stock market strength indicators, traders can identify Replimune Group entry and exit signals to maximize returns
Replimune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Replimune's price direction in advance. Along with the technical and fundamental analysis of Replimune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Replimune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0592 | |||
| Jensen Alpha | 0.2984 | |||
| Total Risk Alpha | 0.0417 | |||
| Sortino Ratio | 0.0819 | |||
| Treynor Ratio | 0.3138 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.04) | Return On Assets (0.27) | Return On Equity (0.50) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.